This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignee: Regents of the University of Minnesota. Active years: 1998-2017.
Location History:
- Edina, MN (US) (1998)
- Minneapolis, MN (US) (2017)
Company Filing History:
Years Active: 1998-2017
Title: Suck Won Kim: Innovator in Dopamine Receptor Modulation
Introduction
Suck Won Kim is a notable inventor based in Minneapolis, MN (US). He has made significant contributions to the field of pharmacology, particularly in the development of compounds that modulate dopamine receptors. With a total of 2 patents, his work is aimed at addressing various medical conditions.
Latest Patents
One of his latest patents is titled "Ergoline derivatives as dopamine receptor modulators." This invention provides compounds of formula I, wherein R-R have any of the values defined in the specification, and salts thereof. The compounds are useful as dopamine receptor modulators for the treatment of diseases where modulation of dopamine receptors is implicated, such as sexual dysfunction, prolactinoma, Parkinson's disease, and Cushing's disease. Another significant patent is "Use of opioid antagonists to treat impulse-control disorders." This method involves treating individuals afflicted with an impulse-control disorder by administering an amount of one or more opioid receptor antagonists.
Career Highlights
Suck Won Kim is affiliated with the Regents of the University of Minnesota, where he continues to advance research in his field. His work has the potential to impact the treatment of various neurological and psychological disorders.
Collaborations
He has collaborated with notable colleagues, including Peter Dosa and Michael Anthony Walters, contributing to a rich environment of innovation and research.
Conclusion
Suck Won Kim's contributions to the field of dopamine receptor modulation highlight his role as an influential inventor. His patents reflect a commitment to addressing complex medical challenges through innovative solutions.